GlassScriptPhysician profile
Jeffrey Masin
NPI 1982605549
$2,685.21
in general payments reported to CMS, 2019-2025
21 companies · $811 in 2025
The $811 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $90.96 · 2021: $509 · 2022: $395 · 2023: $326 · 2024: $416 · 2025: $811.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,497 · Education: $56.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,497.38 |
| Education | $56.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $808.30 | 2019-2025 | |
| Optinose US, INC. | $423.59 | 2020-2025 | |
| Glaxosmithkline, LLC. | $316.91 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $265.41 | 2019-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $227.16 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $143.40 | 2022-2025 | Fasenra |
| Sanofi-Aventis U.S. LLC | $89.25 | 2021-2022 | |
| Integra Lifesciences Corporation | $74.60 | 2020-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Kaleo, INC. | $56.04 | 2021-2022 | |
| Alk-Abello, INC | $41.42 | 2019-2025 | Alternaria Tenuis, Pre-Pen, Standardized Mite D. Farinae |
| Inspire Medical Systems, INC. | $36.68 | 2025 | Inspire |
| Stryker Corporation | $28.94 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $28.89 | 2023 | |
| Paratek Pharmaceuticals, INC. | $25.48 | 2025 | Xhance |
| Genentech USA, INC. | $25.00 | 2025 | Xolair |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $21.80 | 2022 | |
| Nobelpharma America, LLC | $19.28 | 2023 | |
| Xoran Technologies LLC | $14.26 | 2023 | Minicat |
| Arbor Pharmaceuticals, INC. | $13.81 | 2019 | |
| Smith+Nephew, INC. | $13.53 | 2019 | |
| Checkpoint Surgical, INC | $11.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Masin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.